Mesalazine/nifedipine

Drug Profile

Mesalazine/nifedipine

Alternative Names: Mesalamine/nifedipine; Nifedipine/mesalamine; Nifedipine/mesalazine

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bracco
  • Class Aminosalicylic acids; Anti-inflammatories; Dihydropyridines; Small molecules
  • Mechanism of Action Calcium channel antagonists; Lipoxygenase-cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Ulcerative colitis

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Ulcerative-colitis in Italy (Rectal, Enema)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top